Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicinal products containing carbimazole or thiamazole - Important Safety Info from Amdipharm Limited and Essential-Healthcare Ltd as approved by the HPRA
Notice type:
3rd Party Publications
Date:
18/01/2019
Problem Or Issue:
Important Safety Information communication from Amdipharm Limited and Essential-Healthcare Ltd - Medicinal products containing carbimazole or thiamazole (synonym: methimazole): (1) strengthened advice on contraception and (2) risk of acute pancreatitis.
Important Safety Information - Medicinal products containing carbimazole or thiamazole (synonym methimazole)
« Back
Date Printed: 25/04/2024